The AS signature for sphingolipid genes predicted a unique ceramide synthase 2 (CERS2) cassette exon event for exon 8 in Luminal B breast cancer subtype generating an AS transcript that was not identified before. This evidence concerns the gene CERS2 and breast cancer.